Viatris Inc.
NASDAQ:VTRSDrug Manufacturers - Specialty & Generic
-$0.36 today
- Market cap
- $23.25B
- Beta
- 0.90
- P/E (TTM)
- -59.9
- EPS (TTM)
- -$0.26
- Dividend yield
- 3.12%
Volume 13.21M
Average 10.58M
VTRS EBITDA Margin
EBITDA as a percentage of revenue.
Viatris Inc.NASDAQ: VTRS
EBITDA Margin · Q2 FY2026 · quarter ended Jun 2026
EBITDA Margin widens to 19.4%
EBITDA Margin was 19.4% in Q2 FY2026, up 3.3 pp from a year earlier. On a trailing-twelve-month basis it was 18.4%, up 21.9 pp year over year. Over 3 fiscal years it narrowed by 42.3 pp.
Context
- EBITDA Margin widened in 0 of the last 3 fiscal years.
- FY2025 was the lowest level in the 4 fiscal years shown.
What to watch
Whether EBITDA Margin reaches the consensus estimate from 7 analysts of 45.0% for the fiscal year ending Dec 2026, up from -2.8% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- 19.4%+1.1 pp QoQ
- Last fiscal yearDec 2025
- -2.8%-20.6 pp YoY
- LTMJun 2026
- 18.4%+21.9 pp YoY
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- -2.8%
- Year-over-year change
- -20.6pp
| Period | Period end | EBITDA Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | -2.8% | -20.6pp |
| FY2024 | 2024-12-31 | 17.9% | -4.9pp |
| FY2023 | 2023-12-31 | 22.8% | -16.8pp |
| FY2022 | 2022-12-31 | 39.6% | +14.5pp |
| FY2021 | 2021-12-31 | 25.0% | — |
EBITDA Margin vs competitors
How VTRS compares with its peers on the latest reported figures
- VTRS's LTM Jun 2026 EBITDA Margin of 18.4% is the 7th highest of the 10 companies compared; the peer median is 20.9%.
- Its year-over-year change of +21.9 pp is the highest of 9, against a peer median of -6.3 pp.
- Over three fiscal years its change of -42.3 pp compares with a peer median of +0.2 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Mar 2026 | 26.6% | -9.0 pp | +0.2 pp | |
| LTM Mar 2026 | 25.4% | +15.5 pp | +15.5 pp | |
| LTM Jun 2025 | 24.4% | — | +6.0 pp | |
| LTM Sep 2026 | 21.2% | -3.6 pp | -7.7 pp | |
| LTM Jun 2026 | 20.9% | +0.5 pp | +0.1 pp | |
| LTM Jun 2026 | 18.9% | -14.3 pp | -4.5 pp | |
| LTM Jun 2026 | 18.4% | +21.9 pp | -42.3 pp | |
| LTM Sep 2026 | 16.3% | -12.5 pp | -6.7 pp | |
| LTM Jun 2026 | 15.0% | -2.9 pp | +24.4 pp | |
| LTM Sep 2026 | 10.2% | -18.5 pp | +17.0 pp | |
| Peer median (excluding VTRS) | 20.9% | -6.3 pp | +0.2 pp | |
Competitors are the stored peer set for VTRS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 17.89B | 16.26B | 15.43B | 14.74B | 14.3B |
| Cost of Revenue | 12.31B | 9.77B | 8.99B | 9.12B | 9.29B |
| Gross Profit | 5.58B | 6.5B | 6.44B | 5.62B | 5.01B |
| Gross Margin | 31.2% | 40.0% | 41.7% | 38.2% | 35.1% |
| Research & Development | 681M | 662.2M | 805.2M | 808.7M | 965.9M |
| Selling, General & Admin | 4.53B | 4.18B | 4.65B | 4.43B | 3.79B |
| Operating Expenses | 5.61B | 4.88B | 5.67B | 5.61B | 7.68B |
| Depreciation & Amortization | 4.51B | 3.03B | 2.74B | 2.71B | 2.8B |
| EBITDA | 4.48B | 6.43B | 3.52B | 2.64B | (395.4M) |
| EBITDA Margin | 25.0% | 39.6% | 22.8% | 17.9% | -2.8% |
| Operating Income | (34M) | 1.61B | 766.2M | 10.1M | (2.66B) |
| Operating Margin | -0.2% | 9.9% | 5.0% | 0.1% | -18.6% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 636.2M | 592.4M | 573.1M | 550M | 471.3M |
| Other Income / Expenses | (630.4M) | 1.2B | (563.3M) | (633.3M) | (1B) |
| Income Before Tax | (664.4M) | 2.81B | 202.9M | (623.2M) | (3.67B) |
| Pre-Tax Margin | -3.7% | 17.3% | 1.3% | -4.2% | -25.6% |
| Income Tax Expense | 604.7M | 734.6M | 148.2M | 11M | (150.1M) |
| Net Income | (1.27B) | 2.08B | 54.7M | (634.2M) | (3.51B) |
| Net Margin | -7.1% | 12.8% | 0.4% | -4.3% | -24.6% |
| EPS (Basic) | (1.05) | 1.71 | 0.05 | (0.53) | (3.00) |
| EPS (Diluted) | (1.05) | 1.71 | 0.05 | (0.53) | (3.00) |
| Weighted Avg Shares | 1.21B | 1.21B | 1.2B | 1.19B | 1.17B |
| Weighted Avg Shares (Diluted) | 1.21B | 1.22B | 1.21B | 1.19B | 1.17B |
Viatris Inc.
NASDAQ:VTRS
Intrinsic Alpha fair value
Locked
Current Price
$20.28
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.